Inspire Medical Systems, Inc.
INSPInspire Medical Systems, Inc. develops and commercializes medical devices for the treatment of sleep apnea. The company's flagship device, the Inspire Therapy system, uses neurostimulation technology to stimulate the hypoglossal nerve, helping to keep the airway open during sleep. Founded in 2007 and headquartered in Minneapolis, Minnesota, Inspire aims to provide an alternative to traditional sleep apnea treatments such as CPAP machines.
Company News
A class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) alleging that the company made materially false and misleading statements regarding market demand for Inspire V and its readiness for product launch. The lawsuit covers investors who purchased securities between August 6, 2024 and August 4, 2025. The law firm...
A class action securities fraud lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) alleging the company misled investors about its Inspire V device launch readiness. The company failed to prepare clinicians and payors for the rollout, resulting in significant delays and weak demand. On August 4, 2025, Inspire disclosed the ...
Rosen Law Firm is reminding investors in Gauzy Ltd., Klarna Group plc, and Inspire Medical Systems, Inc. about upcoming deadlines to join securities class action lawsuits. The firm is seeking lead plaintiffs for cases involving alleged false statements and material omissions by company defendants.
Rosen Law Firm has filed securities class action lawsuits against multiple companies. The primary case involves Klarna Group plc, alleging the company made false statements in its September 2025 IPO registration statement by understating risks related to loss reserves for buy-now-pay-later loans. The firm is seeking lead plaintiffs with a Februar...
Rosen Law Firm announces a securities class action lawsuit against Inspire Medical Systems, Inc. (NYSE: INSP) for investors who purchased stock between August 6, 2024 and August 4, 2025. The lawsuit alleges that defendants misrepresented key facts about the Inspire V sleep apnea device, including actual market demand and launch readiness. The lea...
